OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine
Chaoli Huang, Zifeng Wu, Di Wang, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 6, pp. 1741-1753
Closed Access | Times Cited: 18
Chaoli Huang, Zifeng Wu, Di Wang, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 6, pp. 1741-1753
Closed Access | Times Cited: 18
Showing 18 citing articles:
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 29
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 29
Spatial Transcriptomics: A Powerful Tool in Disease Understanding and Drug Discovery
Junxian Cao, Caifeng Li, Zhao Cui, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2946-2968
Open Access | Times Cited: 16
Junxian Cao, Caifeng Li, Zhao Cui, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2946-2968
Open Access | Times Cited: 16
(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders
Hana Shafique, Julie Demers, Julia Biesiada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6804-6804
Open Access | Times Cited: 12
Hana Shafique, Julie Demers, Julia Biesiada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6804-6804
Open Access | Times Cited: 12
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 12
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 12
Linking depression and neuroinflammation: crosstalk between glial cells
Xueying Yang, Huiqin Wang, Zhen‐Zhen Wang, et al.
European Journal of Pharmacology (2025), pp. 177408-177408
Closed Access | Times Cited: 1
Xueying Yang, Huiqin Wang, Zhen‐Zhen Wang, et al.
European Journal of Pharmacology (2025), pp. 177408-177408
Closed Access | Times Cited: 1
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 8
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 8
Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1
Dan Xu, Guilin Liu, Mingming Zhao, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 745-755
Open Access | Times Cited: 6
Dan Xu, Guilin Liu, Mingming Zhao, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 745-755
Open Access | Times Cited: 6
Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice
Mingming Zhao, Tingting Zhu, Dan Xu, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177096-177096
Open Access | Times Cited: 6
Mingming Zhao, Tingting Zhu, Dan Xu, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177096-177096
Open Access | Times Cited: 6
Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023
Li-yuan Zhao, Guang-Fen Zhang, Xue-jie Lou, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 5
Li-yuan Zhao, Guang-Fen Zhang, Xue-jie Lou, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 5
S-ketamine alleviates morphine-induced hyperalgesia via decreasing the gut Enterobacteriaceae levels: Comparison with R-ketamine
Hanyu Liu, Siqi Yang, Qi Zhang, et al.
Neuroscience (2025)
Closed Access
Hanyu Liu, Siqi Yang, Qi Zhang, et al.
Neuroscience (2025)
Closed Access
Genome-wide analysis identifies novel shared loci between depression and white matter microstructure
Qiyu Zhao, Shuo Wang, Di Xiong, et al.
Molecular Psychiatry (2025)
Open Access
Qiyu Zhao, Shuo Wang, Di Xiong, et al.
Molecular Psychiatry (2025)
Open Access
Stress-Induced Cholesterol Metabolic Dysregulation and Differentiation Trajectory Shift in Oligodendrocytes Synergistically Drive Demyelination
Weihao Zhu, Rui Shi, Yingmin Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3517-3517
Open Access
Weihao Zhu, Rui Shi, Yingmin Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3517-3517
Open Access
Demyelination in Psychiatric and Neurological Disorders: Mechanisms, Clinical Impact, and Novel Therapeutic Strategies
Rumi Murayama, Yi Cai, Hiroyuki Nakamura, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106209-106209
Open Access
Rumi Murayama, Yi Cai, Hiroyuki Nakamura, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106209-106209
Open Access
Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential
Qianting Deng, Emily D. Parker, Chongyun Wu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Qianting Deng, Emily D. Parker, Chongyun Wu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression
Jesca E. De Jager, Rutger Boesjes, Gijs H.J. Roelandt, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105796-105796
Closed Access | Times Cited: 3
Jesca E. De Jager, Rutger Boesjes, Gijs H.J. Roelandt, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105796-105796
Closed Access | Times Cited: 3
Effect of Xiaoyaosan on brain volume and microstructure diffusion changes to exert antidepressant-like effects in mice with chronic social defeat stress
Yongxin Li
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Yongxin Li
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Ketamine attenuates kidney damage and depression-like behaviors in mice with cisplatin-induced acute kidney injury
Tianwen Huang, Yangyang He, Ruijuan Cheng, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
Tianwen Huang, Yangyang He, Ruijuan Cheng, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation
Tingting Zhu, Mingming Zhao, Dan Xu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111228-111228
Open Access
Tingting Zhu, Mingming Zhao, Dan Xu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111228-111228
Open Access
Myelination mediates benefits of ketamine
Ian Fyfe
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 711-711
Closed Access
Ian Fyfe
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 711-711
Closed Access
